Browse by Poster Presenter

Skip to main content

ACoP 2024 Main banner

Conference Program

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

P
Paleja, Bhairav

Vantage Research
(T-010) A quantitative systems pharmacology model framework for combined clinical efficacy and hematological toxicity predictions for antibody drug conjugates
Bhairav Paleja
Favorite
Panetta, John

St Jude Children's Research Hospital
(M-088) Modeling Effects of Dose, Schedule, and Pharmacokinetics of Fludarabine Lymphodepletion Therapy on CAR T-cell and Cytokine Dynamics
John Panetta
Favorite
Papadopoulos, Stefanos

University of Pittsburgh
(T-095) Modeling the Role of Organ Crosstalk and Cellular Adaptation in Multiple Organ Dysfunction Syndrome
Stefanos Papadopoulos
Favorite
Parikh, Sanjana

College of Pharmacy University of Cincinnati, Cincinnati Children's Hospital Medical Center
(W-090) Physiologically Based Pharmacokinetic Model of Vedolizumab in Adult Patients with Inflammatory Bowel Disease
Sanjana Parikh
Favorite
Paris, Alessio

Fondazione The Microsoft Research - University of Trento Centre for Computational and Systems Biology (COSBI), Rovereto, Italy
(T-096) Integrating Motor Function Scores of Spinal Muscular Atrophy in a Quantitative Systems Pharmacology Model of Neurofilament
Alessio Paris
Favorite
Parker, Robert

Departments of Chemical and Petroleum Engineering and Critical Care Medicine; University of Pittsburgh
(T-097) Model Predictive Control Regulates Blood Pressure During Simulated Kidney Replacement Therapy
Robert Parker
Favorite
Park, Hyunseo

UTHSC, College of Pharmacy
(W-091) Characterization of the Effect of Biofilm Formation on the Antimicrobial Activity of Tigecycline against M. abscessus using a Hollow Fiber Infection Model and Pharmacokinetic/Pharmacodynamic Modeling
Hyunseo Park
Favorite
Park, Seongwon

Chungnam National University
(W-028) Development and application of physiologically based pharmacokinetic model of darunavir on pregnant population
Seongwon Park
Favorite
(W-093) Integration of Population Pharmacokinetic Model for Tenofovir Alafenamide by External Evaluation
Seongwon Park
Favorite
Park, Taeshin

RES Group Inc
(W-092) Incorporating Computational Fluid Dynamic Modeling into Pharmacometrics Models for Applications to Gene Therapy, Anti-Inflammatory Treatments and Transdermal Patch Drug Delivery
Taeshin Park
Favorite
Park, Wansu

Alnylam Pharmaceuticals
(W-094) Population Pharmacokinetic/Pharmacodynamic Analysis of Cemdisiran (ALN-CC5) in Healthy Subjects and Patients with Immunoglobulin A Nephropathy
Wansu Park
Favorite
Patidar, Krutika

University at Buffalo
(M-089) A minimal PBPK model to study the effect of antibody size, charge, and binding affinity to FcRn/antigen on antibody PK
Krutika Patidar
Favorite
Pendse, Salil

Allucent
(W-095) Physiologically Based Pharmacokinetic (PBPK) modeling of hepatic impairment using PK-Sim
Salil Pendse
Favorite
Pichardo, Cesar

Systems Medicine, Clinical Pharmacology & Quantitative Pharmacology, R&D BioPharmaceuticals, AstraZeneca, Cambridge, UK
(W-096) Quantitative Systems Pharmacology of T-cell Engagers and Cytokine Release
Cesar Pichardo
Favorite
Pillai, Nikhil

Sanofi
(W-097) Predicting pharmacokinetic profile of small molecule drugs based on chemical structure using machine learning.
Nikhil Pillai
Favorite
Piscitelli, Joseph

Pfizer Inc., La Jolla, CA, USA
(T-098) Population pharmacokinetic modeling of Binimetinib in Healthy Volunteers and Participants with BRAF V600-mutant or NRAS-mutant Solid Tumors
Joseph Piscitelli
Favorite
Poels, Kamrine

Pfizer
(W-098) Role of quantitative systems pharmacology (QSP) in optimizing elranatamab dosing regimen for relapsed/refractory multiple myeloma
Kamrine Poels
Favorite
Poland, Bill
(T-099) Acoramidis (ALXN2060) Population Pharmacokinetic Modeling and the Importance of Exploring Categorization of Covariate Values
Bill Poland
Favorite
Poon, Victor

Genentech
(W-099) Constructing a virtual control arm and evaluating operating characteristics using TGI metrics to support go/no-go decisions for single-arm Phase Ib/II combination studies
Victor Poon
Favorite
Pourzanjani, Arya

Amgen
(M-090) A Novel Approach to Capturing the Dynamics of Nontarget and New Tumors in Mechanistic Models of Progression-Free Survival
Arya Pourzanjani
Favorite
(M-091) Fully Bayesian Covariate Selection in Population Pharmacokinetics and Pharmacodynamics Models Using Regularized Horseshoe Priors
Arya Pourzanjani
Favorite
Purohit, Prasad
(M-092) Integrated Quantitative Systems Pharmacology and Pharmacometric Model to Evaluate Effective Buprenorphine Induction Treatment Strategies in the Era of Synthetic Opioids
Prasad Purohit
Favorite